TY  - JOUR
AU  - Haun, Jolie N
AU  - Ballistrea, Lisa M
AU  - Melillo, Christine
AU  - Standifer, Maisha
AU  - Kip, Kevin
AU  - Paykel, Jacquelyn
AU  - Murphy, Jennifer L
AU  - Fletcher, Carol E
AU  - Mitchinson, Allison
AU  - Kozak, Leila
AU  - Taylor, Stephanie L
AU  - Glynn, Shirley M
AU  - Bair, Matthew
PY  - 2019
DA  - 2019/05/13
TI  - A Mobile and Web-Based Self-Directed Complementary and Integrative Health Program for Veterans and Their Partners (Mission Reconnect): Protocol for a Mixed-Methods Randomized Controlled Trial
JO  - JMIR Res Protoc
SP  - e13666
VL  - 8
IS  - 5
KW  - health information technology
KW  - implementation
KW  - veteran
KW  - complementary and integrative health
KW  - PTSD
KW  - pain
AB  - Background: Complementary and integrative health (CIH) is a viable solution to PTSD and chronic pain. Many veterans believe CIH can be performed only by licensed professionals in a health care setting. Health information technology can bring effective CIH to veterans and their partners. Objective: This paper describes the rationale, design, and methods of the Mission Reconnect protocol to deliver mobile and Web-based complementary and integrative health programs to veterans and their partners (eg, spouse, significant other, caregiver, or family member). Methods: This three-site, 4-year mixed-methods randomized controlled trial uses a wait-list control to determine the effects of mobile and Web-based CIH programs for veterans and their partners, or dyads. The study will use two arms (ie, treatment intervention arm and wait-list control arm) in a clinical sample of veterans with comorbid pain and posttraumatic stress disorder, and their partners. The study will evaluate the effectiveness and perceived value of the Mission Reconnect program in relation to physical and psychological symptoms, global health, and social outcomes. Results: Funding for the study began in November 2018, and we are currently in the process of recruitment screening and data randomization for the study. Primary data collection will begin in May 2019 and continue through May 2021. Projected participants per site will be 76 partners/dyads, for a total of 456 study participants. Anticipated study results will be published in November 2022. Conclusions: This work highlights innovative delivery of CIH to veterans and their partners for treatment of posttraumatic stress disorder and chronic pain. Trial Registration: ClinicalTrials.gov NCT03593772; https://clinicaltrials.gov/ct2/show/NCT03593772 (Archived by WebCite at http://www.webcitation.org/77Q2giwtw) International Registered Report Identifier (IRRID): PRR1-10.2196/13666 
SN  - 1929-0748
UR  - http://www.researchprotocols.org/2019/5/e13666/
UR  - https://doi.org/10.2196/13666
UR  - http://www.ncbi.nlm.nih.gov/pubmed/31094345
DO  - 10.2196/13666
ID  - info:doi/10.2196/13666
ER  -